Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Allogeneic Stem Cell Transplantation for Children With CML

NCT02707393

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Universitätsklinik für Kinder- und Jugendheilkunde Graz, Austria
  • St. Anna Kinderspital Vienna, Austria
  • Hospital Motol, Department of Pediatric Hematology and Oncology, BMT Unit Prague, Czechia
  • Clinica Pediatrica Monza, Italy
View Trial Details
Completed

Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00372593

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner Desert Medical Center Mesa, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
View all 198 locations
View Trial Details
Completed

Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

NCT01338987

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +25 more
Locations
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • University of Oklahoma Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Pediatric Disease Registry in Essential Thrombocythaemia (ET)

NCT01198717

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Paediatric Clinic University Hospital Olomouc Olomouc, Czechia
  • Clinic of Paediatric haematology and oncology University Hospital Motol Prague, Czechia
  • Paediatric Oncology Unit, Hopital Cote De Nacre Caen, France
  • Practicen Hospitalier , Institute d'Hematologie et Oncologie Pediatrique Lyon, France
View all 32 locations
View Trial Details
Completed

Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)

NCT01207440

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +12 more
Locations
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Alfred Hospital Box Hill, Victoria, Australia
View all 42 locations
View Trial Details
Completed

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT01445080

Conditions
Blast Crisis, Blastic Phase, Bone Marrow Diseases, +33 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details

Related conditions